Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain

By Nicholson Bruce   Ross Edgar   Sasaki John   Weil Arnold  

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1503-1514

Informa Healthcare

Access to resources Recommend Favorite

Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules

By Nicholson Bruce   Ross Edgar   Weil Arnold   Sasaki John   Sacks Gerald  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 539-550

Informa Healthcare

Access to resources Recommend Favorite

Controlled-Release Oxycodone in the Treatment of Neuropathic Pain of Nonmalignant and Malignant Causes

By  

Oncology, Vol. 74, Iss. 1, 2008-08 ,pp. : 72-75

Karger

Access to resources Recommend Favorite

Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine

By Radbruch Lukas   Lehmann K.   Gockel H.-H.   Neighbors D.   Nuyts G.  

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 111-119

Springer Publishing Company

Access to resources Recommend Favorite

Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 12, 2015-12 ,pp. : 1351-1361

John Wiley & Sons Inc

Access to resources Recommend Favorite